NEWS
The information contained in each news post on this page was factually accurate on the date it was issued and posted.
Aglycosylated Antibodies and Antibody Fragments Produced in a Scalable in Vitro Transcription-Translation System
Gang Yin, Eudean D. Garces, Junhao Yang, Juan Zhang, Cuong Tran, Alexander R. Steiner, Christine Roos, Sunil Bajad, Susan Hudak, Kalyani Penta, James Zawada, Sonia Pollitt and Christopher J. Murray, Aglycosylated antibodies and antibody fragments produced in a...
Sutro Announces Newly Formed Scientific Advisory Board Renowned Researchers James A. Wells, Ph.D., and James R. Swartz, Sc.D., to Guide Sutro’s Advancing Therapeutic Pipeline
SAN FRANCISCO, Jan. 7, 2012 - Sutro Biopharma, a biopharmaceutical company developing novel and biosuperior protein therapeutics with improved pharmaceutical properties, today announced that it has appointed James A. Wells, Ph.D., and James R. Swartz, Sc.D., to its...
Sutro Biopharma’s Trevor Hallam Offers a Glimpse into the Future of Drug Design
12/5/2011 - BioPharm International Podcast (3of3): Sutro Biopharma's Trevor Hallam offers a glimpse into the future of drug design By: Trevor J. Hallam
Sutro Biopharma’s Trevor Hallam Describes a Future cGMP Manufacturing Facility
BioPharm International Podcast (2of3): Sutro Biopharma's Trevor Hallam describes a future cGMP manufacturing facility By: Trevor J. Hallam
Sutro Biopharma and Cell-Free Protein Expression Systems
BioPharm International Podcast (1of3): Sutro Biopharma and Cell-Free Protein Expression Systems By: Trevor J. Hallam
Preparation and Testing of E. coli S30 In Vitro Transcription Translation Extracts
James F. Zawada, Preparation and Testing of E. coli S30 In Vitro Transcription Translation ExtractsRibosome Display and Related Technologies Methods in Molecular Biology Volume 805, 2012, pp 31-41 Date: 20 Oct 2011 Read More ...
Sutro Biopharma to Present its Biochemical Protein Synthesis Technology at BioProduction Conference 2011 in Berlin
SAN FRANCISCO, Oct. 17, 2011 - Sutro's Chief Scientific Officer, Trevor Hallam, Ph.D., to Highlight Company's Technology Platform for the Highly Specific Design and Manufacturing of Novel Protein Therapeutics Sutro Biopharma, a biopharmaceutical company developing...
Study Shows Sutro Biopharma’s Biochemical Protein Synthesis Technology Enables Rapid Production and Scale-Up of Biopharmaceuticals Results Published in Biotechnology and Bioengineering Demonstrate that Cell-Free Production of a Biologically Active Human Cytokine Can be Scaled-up to Commercial Manufacturing Levels Study Featured in Journal’s Spotlight Section.
SAN FRANCISCO, May 19, 2011 - Sutro Biopharma, a biopharmaceutical company developing novel and biosuperior protein therapeutics with improved pharmaceutical properties, today announced that a study published in the July issue of Biotechnology and...
Microscale to Manufacturing Scale-up of Cell-Free Cytokine Production: A New Approach for Shortening Protein Production Development Timelines
James F. Zawada, Gang Yin, Alexander R. Steiner, Junhao Yang, Alpana Naresh, Sushmita M. Roy, Daniel S. Gold, Henry G. Heinsohn, Christopher J. Murray, Microscale to Manufacturing Scale-up of Cell-Free Cytokine Production—A New Approach for Shortening Protein...
Microscale to Manufacturing Scale-up of Cell-Free Cytokine Production: A New Approach for Shortening Protein Production Development Timelines
PHARMACEUTICAL TECHNOLOGY Volume 35, pp. s8-s11 Industrializing Design, Development, and Manufacturing of Therapeutic Proteins By: Trevor J. Hallam, Christopher J. Murray.